ADC · 담도암 · 담낭

3개 · ADC 890 · Antibody 4097 · CGT 2985 · 다음 갱신 D-6 · 마지막 9월 2일

PopularRecently updatedCuratedMost trialsNeeds refreshORRLatestPhase 3FDA approved3 programs
ADCLimited DatastaleRemeGenPreclinical

disitamab vedotin (Disitamab Vedotin, RC48, Disitamab Vedotin combined with Zimberelizumab)

Biliary Carcinoma · Biliary Carcinoma

#BiliaryCarcinoma#ADC#Preclinical#antibody-drug-conjugate#RemeGen
Trials 1Status Active
ADCLimited DatastaleSichuan Kelun-Biotech Biopharma…Phase 2

SKB264 (Sacituzumab Tirumotecan, Sacituzumab Tirumotecan (SKB264))

Advanced Biliary Tract Cancer(BTC) · Advanced Biliary Tract Cancer(BTC)

#AdvancedBiliaryTractCancerBTC#ADC#Phase2#antibody-drug-conjugate#Sichuan
Trials 1Status Recruiting
ADCLimited DatastaleTianjin Medical University Canc…Phase 2

sacituzumab govitecan (Trodelvy, Sacituzumab tirumotecan combined with envafolimab)

Advanced Biliary Tract Cancers · Advanced Biliary Tract Cancers

#AdvancedBiliaryTractCancers#ADC#Phase2#antibody-drug-conjugate#Tianjin
Trials 1Status Recruiting